Adults who?ve smoked daily for at least the past year who want to quit their habit within the next 30 days are needed for a study of a quit-smoking iPhone app being conducted by Fred Hutchinson Cancer Research Center in collaboration with the University of Washington and 2Morrow Mobile. Study enrollment will end May 11, 2013.

The clinical trial led by Jonathan Bricker, Ph.D., a psychologist and an associate member of the Fred Hutch Public Health Sciences Division, will randomly assign participants to one of two iPhone application quit-smoking programs. The goal of the study is to learn which of the two programs is the most useful for people who are quitting smoking. Commenting on the Smart Quit study, Bricker noted: ?This is the first-ever study of any smartphone app for quitting smoking. Smartphones are a potentially revolutionary quit-smoking tool because you can carry that support with you anywhere.?

Randomly assigned participants will receive:

  • Interactive tools for dealing more effectively with urges to smoke
  • A step-by-step guide for quitting smoking
  • Personalized plans for quitting and staying quit

Participation in the study is free. They will be asked to complete online questionnaires, including one brief follow-up survey during the next two months. Each of the participants will receive $25 after completing the two-month follow-up survey. Eligibility criteria include:

  • being age 18 or older
  • having smoked at least five cigarettes daily for at least the past 12 months
  • wanting to quit in the next 30 days
  • being interested in learning skills to quit smoking

For more information
Smart Quit iPhone study

Advertisement #3

Photo Jonathan Bricker, Ph.D., principal investigator of the Smart Quit study, is a psychologist based in the Public Health Sciences Division at Fred Hutchinson Cancer Research Center.Photo by Bo Jungmayer; Courtesy Fred Hutchinson Cancer Research Center

Copyright ? 2013 InPress Media Group/Sunvalley Communication. All rights reserved. Republication or redistribution of InPress Media Group/Sunvalley Communication content, including by framing or similar means, is expressly prohibited without the prior written consent of InPress Media Group/Sunvalley Communication. InPress Media Group/Sunvalley Communication shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Onco’Zine and Oncozine are registered trademarks and trademarks of Sunvalley Communication around the world.

Advertisement #5